In the News
Shelby Trieu
EDSA Announces 2025 Catalyst Award Honorees, ...

Congratulations to Project PROTECT, recently honored with the 2025 EDSA Catalyst Award for Outstanding Industry Collaboration from the End Drug Shortages Alliance. This award honors a multi-stakeholder partnership that has measurably improved drug access and strengthened supply resilience through cooperation, transparency, and innovation.

This award is especially meaningful because it reflects what Project PROTECT was built on from the very beginning: collaboration, ingenuity, and a shared commitment to protecting patients from essential medicine shortages. Together, Angels for Change, STAQ Pharma, and the Children’s Hospital Association designed and launched a model that brings hospitals, advocacy groups, manufacturers, and supply chain experts around one table to strengthen the stability of the drug supply chain. 

EDSA Announces 2025 Catalyst Award Honorees, Celebrating ‘Progress Through Partnership’ in Strengthening Drug Supply Resilience
In the News
Shelby Trieu
EDSA Advances Shared Mission to End Drug ...

The End Drug Shortages Alliance (EDSA), co-founded by Angels for Change and Vizient, has grown to more than 100 members across the healthcare supply chain. The article highlights how this expanding organization is advancing transparency, data-sharing and coordinated action to strengthen access to essential medicines. Recent progress includes a pilot with children’s hospitals and distributors focused on improving visibility for critical pediatric oncology drugs. The alliance’s continued growth reflects a shared commitment to building a more resilient, patient-centered supply chain.

EDSA Advances Shared Mission to End Drug Shortages with 100+ Members
A4C News
Shelby Trieu
2024 Annual Report
2024 Annual Report
In the News
Shelby Trieu
A4C Statement Featured in Congressional Hearing

Angels for Change Statement Included in Congressional Hearing on Strengthening the U.S. Health Care Supply Chain

Last month, the House Energy & Commerce Health Subcommittee held a critical hearing titled: “Made in America: Strengthening Domestic Manufacturing and Our Health Care Supply Chain.”

Angels for Change submitted a formal statement for the record—bringing the voice of the patient directly to policymakers.

A4C Statement Featured in Congressional Hearing
In the News
Laura Bray
Bipartisan MAPS Act Introduced to Congress

New Legislation Takes Aim at Drug Shortages—Angels for Change Recognized in MAPS Act Launch

Angels for Change is officially recognized in the introduction of the bipartisan Mapping America’s Pharmaceutical Supply (MAPS) Act, a groundbreaking bill introduced by Representatives Doris Matsui (D-CA) and Dan Crenshaw (R-TX). This legislation directly addresses vulnerabilities in the drug supply chain by requiring greater transparency, mapping critical drug components, and identifying potential risks before they impact patient care

Bipartisan MAPS Act Introduced to Congress

A4C News

Angels for Change Goes ALL IN on Ending Drug Shortages with Fifth Annual SummitONE Conference

Angels for Change Goes ALL IN on Ending Drug Shortages with Fifth Annual SummitONE Conference

Angels for Change, a nonprofit organization dedicated to ending drug shortages, hosted the fifth annual SummitONE conference on July 8 and 9 at Fresenius Kabi’s U.S. headquarters in Lake Zurich, Illinois. SummitONE is the only annual conference that gathers supply chain leaders, drug shortage experts, policy makers, and patients to discuss solutions to end drug shortages.

Issue 8, Quarter 1, 2024 of The Changemaker Chronicle

Issue 8, Quarter 1, 2024 of The Changemaker Chronicle

Read the latest Issue 8, Quarter 1, 2024 of The Changemaker Chronicle! Dive into our 1st quarter to learn how we supported patients with new shortage stories, attended the Capitol Hill briefing in DC, and spread awareness on Voice of America, CNN’s Top 10 Health Stories of 2023, and more! We invite you to journey along as we build supply chain resiliency through collaborative solutions nationwide with key pharmaceutical supply chain leaders.